Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Urbig
T Cell-Engaging BiTE Antibodies Specific for EGFR Potently Eliminate KRAS- And BRAF-mutated Colorectal Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers in Oncology
Cancer Research
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
BRAF-mutated Metastatic Colorectal Cancer Between Past and Future
British Journal of Cancer
Cancer Research
Oncology
Lauric Acid Can Improve the Sensitization of Cetuximab in KRAS/BRAF Mutated Colorectal Cancer Cells by Retrievable microRNA-378 Expression
Oncology Reports
Medicine
Cancer Research
Oncology
Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients
Neoplasma
Cancer Research
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations
Oncotarget
Oncology
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Concomitant Inhibition of Receptor Tyrosine Kinases and Downstream AKT Synergistically Inhibited Growth of KRAS/BRAF Mutant Colorectal Cancer Cells
Oncotarget
Oncology